Fluticasone propionate / Salmeterol xinafoate inhalers [Regulatives / Guidelines]

posted by ElMaestro  – Denmark, 2014-08-22 23:49 (4328 d 03:58 ago) – Posting: # 13422
Views: 4,747

Hi all,

new paper published about the US Fp/Sx conundrum.

It isn't difficult to conduct any of the individual trials suggested by the draft guidance, but showing equivalence in all of them is very demanding in terms of sample sizes. Especially when no good IVIVC predictor method exists.

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
267 visitors (0 registered, 267 guests [including 22 identified bots]).
Forum time: 03:47 CEST (Europe/Vienna)

Most scientists today are devoid of ideas, full of fear, intent on
producing some paltry result so that they can add to the flood
of inane papers that now constitutes “scientific progress”
in many areas.    Paul Feyerabend

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5